Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741. (Q45095320)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2004

Language	Label	Description	Also known as
English	Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.	scientific article published in November 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Daniel J. Sargent

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Charles S. Fuchs

5

object named as

Charles S Fuchs

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Thierry Delaunoit

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Richard M Goldberg

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Roscoe F Morton

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Brian P Findlay

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sachdev P Thomas

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Muhammad Salim

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Paul L Schaefer

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Philip J Stella

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Erin Green

11

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

James A Mailliard

12

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

2170-2176

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20594

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45095320&oldid=1566614615"